ArticleExpert review of hematology2023

An evaluation of deferiprone as twice-a-day tablets or in combination therapy for the treatment of transfusional iron overload in thalassemia syndromes.

Richa Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.